- Home
- VRTS vs ETON Comparison
VRTS vs ETON Comparison
Compare VRTS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRTS | ETON |
|---|---|---|
| Founded | 1988 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.0M | 872.7M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VRTS | ETON |
|---|---|---|
| Price | $151.57 | $37.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $158.00 | $39.33 |
| AVG Volume (30 Days) | 87.0K | ★ 399.8K |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | ★ 6.68% | N/A |
| EPS Growth | ★ 18.24 | N/A |
| EPS | ★ 1.05 | 0.05 |
| Revenue | N/A | ★ $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | $1.66 | $47.23 |
| P/E Ratio | ★ $144.35 | $750.00 |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $121.61 | $13.76 |
| 52 Week High | $214.88 | $37.98 |
Technical Indicators
Market Signals| Indicator | VRTS | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 61.04 | 73.80 |
| Support Level | $135.84 | $15.77 |
| Resistance Level | $169.44 | N/A |
| Average True Range (ATR) | 5.98 | 1.52 |
| MACD | 0.65 | 0.40 |
| Stochastic Oscillator | 99.02 | 93.30 |
Price Performance
Historical ComparisonAbout VRTS Virtus Investment Partners Inc.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.